Point-Of-Care Testing (POCT) Market in Europe 2024-2028
The point-of-care testing (POCT) market in europe is forecasted to grow by $ 6751 mn during 2023-2028, accelerating at a CAGR of 8.38% % during the forecast period. The report on the point-of-care testing (POCT) market in europe provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing geriatric population, increased focus on personalized medicine, and growing adoption of automated diagnostic devices in healthcare industry.
Technavio's point-of-care testing (POCT) market in europe is segmented as below:
- By Type
- OTC testing
- Prescription- based testing
- By Application
- Blood glucose testing
- Infectious diseases testing
- Cardiac markers testing
- Pregnancy and fertility testing
- Others
- By Geographical Landscape
- Europe
This study identifies the shift from conventional testing methods to rapid diagnostic test as one of the prime reasons driving the point-of-care testing (POCT) market in europe growth during the next few years. Also, technological advances in diagnostics and increasing focus on introducing low-cost test strips will lead to sizable demand in the market.
The report on the point-of-care testing (POCT) market in europe covers the following areas:
- Point-Of-Care Testing (POCT) Market in Europe sizing
- Point-Of-Care Testing (POCT) Market in Europe forecast
- Point-Of-Care Testing (POCT) Market in Europe industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading point-of-care testing (POCT) market in europe vendors that include A. Menarini Industrie Farmaceutiche Riunite Srl, Abbott Laboratories, ACON Laboratories Inc., Becton Dickinson and Co., BioMerieux SA, Chembio Diagnostics Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Fluxergy Inc., Johnson and Johnson Services Inc., LifeScan IP Holdings LLC, Nova Biomedical Corp., OraSure Technologies Inc., PHC Holdings Corp., Sd Biosensor Inc., Siemens AG, Sinocare Inc., Sysmex Corp., Thermo Fisher Scientific Inc., and Trinity Biotech Plc. Also, the point-of-care testing (POCT) market in europe analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.